Director Clinical Pharmacology & DMPK
Alumis
About this role
Alumis Inc. is a precision medicines company focusing on autoimmune diseases. They are looking for a Director of Clinical Pharmacology & DMPK to lead strategy, modeling, and analysis for their small-molecule programs in immune-mediated diseases.
Skills
Qualifications
About Alumis
alumis.comAlumis Inc. is a clinical-stage biopharmaceutical company focused on developing precision therapies for immune-mediated diseases. It advances a late-stage portfolio of next-generation targeted programs — including TYK2 and IGF-1R pathway efforts and assets such as envudeucitinib and lonigutamab — aimed at conditions like psoriasis, SLE and thyroid eye disease. The company combines integrated scientific insights with a proprietary data‑analytics platform to guide therapeutic development and clinical trial strategy. Alumis emphasizes patient-centered development, offering resources and conducting trials to translate its medicines into meaningful improvements in patients’ lives.
Recent company news
Alumis Teases TYK2 Catalysts at Leerink: Phase III Psoriasis Wins, NDA Plan and Lupus Readout Ahead
2 days ago
Raymond James Starts ALMS (Alumis Inc. Common Stock) at Strong Buy Mar 2026
20 hours ago
Raymond James initiates Alumis stock coverage citing psoriasis drug potential
2 days ago
Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock
Jan 9, 2026
Alumis soars as TYK2 drug hits mark in psoriasis trials
Jan 6, 2026
About Alumis
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Alumis.
Salary
$200k – $240k
per year